BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 30999719)

  • 21. Evaluation of the prognostic value of the new AJCC 8th edition staging system for patients with pancreatic adenocarcinoma; a need to subclassify stage III?
    Song M; Yoon SB; Lee IS; Hong TH; Choi HJ; Choi MH; Lee MA; Jung ES; Choi MG
    Eur J Cancer; 2018 Nov; 104():62-69. PubMed ID: 30326370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis.
    Kamarajah SK; Burns WR; Frankel TL; Cho CS; Nathan H
    Ann Surg Oncol; 2017 Jul; 24(7):2023-2030. PubMed ID: 28213792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of nomogram for Primary Nonfunctional Pancreatic Neuroendocrine Tumors based on the 7th vs 8th edition of the AJCC cancer staging manual.
    Heng X; Chen B; Zhao K; Li J; Wu W; Peng Y; Zhong R
    PLoS One; 2023; 18(4):e0284930. PubMed ID: 37093837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AJCC 7th edition staging classification is more applicable than AJCC 8th edition staging classification for invasive IPMN.
    Fan Z; Cheng H; Jin K; Gong Y; Huang Q; Xu J; Ni Q; Yu X; Liu C; Luo G
    World J Surg Oncol; 2019 Aug; 17(1):137. PubMed ID: 31387646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival in Papillary Thyroid Microcarcinoma: A Comparative Analysis Between the 7th and 8th Versions of the AJCC/UICC Staging System Based on the SEER Database.
    Yang F; Zhong Q; Huang Z; Lian M; Fang J
    Front Endocrinol (Lausanne); 2019; 10():10. PubMed ID: 30733707
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinicopathological features and prognostic validity of the European Neuroendocrine Tumor Society (ENETS) and American Joint Committee on Cancer (AJCC) 8th staging systems in colonic neuroendocrine neoplasms.
    Zhang Y; Shang L; Zhang PP; Chen LH; Wang W; Fang C; Qiu M; Feng XY; Zhou L; Zhang M; Tan HY; Qiu XD; Wang H; Lin R; Zhang Q; Zeng YJ; Jin KZ; Yu XJ; Shen L; Chen MH; Li J; Li LP; Chen J
    Cancer Med; 2019 Sep; 8(11):5000-5011. PubMed ID: 31293053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of the external validity of the American Joint Committee on Cancer 8th staging system for anal carcinoma.
    Oweira H; Giryes A; Mannhart M; Decker M; Schlumpf R; Abdel-Rahman O
    Curr Med Res Opin; 2018 May; 34(5):923-929. PubMed ID: 29448859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Interpretation and evaluation of the American Joint committee on Cancer (AJCC) 8th Edition Staging System for patients with gastroenteropancreatic neuroendocrine tumors].
    Chen L; Zhou Z; Chen J
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):972-976. PubMed ID: 28900985
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Validity of the American Joint Committee on Cancer Eighth Edition TNM Staging System for Surgically Treated and Well-Differentiated Pancreatic Neuroendocrine Tumors: A Comprehensive Analysis of 254 Consecutive Patients From a Large Chinese Institution.
    Yang M; Zhang Y; Zeng L; Ke NW; Tan CL; Tian BL; Xiang B; Liu XB
    Pancreas; 2019; 48(5):613-621. PubMed ID: 31091206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which Staging System Is More Suitable for Gastric Neuroendocrine Cancer and Mixed Adenoneuroendocrine Carcinomas? A Multicenter Cohort Study.
    Lin J; Zhao Y; Zhou Y; Hao H; He Q; Tian Y; Zou B; Zhao G; Qiu X; Jiang L; Li Z; Xu Y; Xue F; Fu W; Xu Z; Li Y; Li S; Chen J; Zhou X; Zhu Z; Li H; Li Y; Li E; Cai L; Jia G; Xie JW; Li P; Zheng CH; Huang CM
    Neuroendocrinology; 2021; 111(11):1130-1140. PubMed ID: 31940636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.
    Nam SH; Bae MR; Roh JL; Gong G; Cho KJ; Choi SH; Nam SY; Kim SY
    Oral Oncol; 2018 Dec; 87():158-164. PubMed ID: 30527232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Staging System for Neuroendocrine Tumors of the Lung Needs to Incorporate Histologic Grade.
    Jackson AS; Rosenthal A; Cattoni M; Bograd AJ; Farivar AS; Aye RW; Vallières E; Louie BE
    Ann Thorac Surg; 2020 Apr; 109(4):1009-1018. PubMed ID: 31706866
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems.
    Yang M; Ke NW; Zhang Y; Zeng L; Tan CL; Zhang H; Mai G; Tian BL; Liu XB
    Medicine (Baltimore); 2015 Dec; 94(48):e2156. PubMed ID: 26632896
    [TBL] [Abstract][Full Text] [Related]  

  • 34. External validation of a modified 8th AJCC TNM system for advanced gastric cancer: Long-term results in southern China.
    Ye J; Ren Y; Wei Z; Hou X; Dai W; Cai S; Tan M; He Y; Yuan Y
    Surg Oncol; 2018 Jun; 27(2):146-153. PubMed ID: 29937164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the 8th AJCC staging system for pathologically versus clinically staged pancreatic adenocarcinoma: A time to revisit a dogma?
    Abdel-Rahman O
    Hepatobiliary Pancreat Dis Int; 2018 Feb; 17(1):64-69. PubMed ID: 29428107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of the AJCC 8th edition staging system for Japanese patients treated with surgery followed by radiotherapy for breast cancer.
    Tang L; Ishikawa Y; Matsushita H; Jingu K
    Int J Clin Oncol; 2020 Aug; 25(8):1499-1505. PubMed ID: 32356049
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single institution's 26-year experience with nonfunctional pancreatic neuroendocrine tumors: a validation of current staging systems and a new prognostic nomogram.
    Ellison TA; Wolfgang CL; Shi C; Cameron JL; Murakami P; Mun LJ; Singhi AD; Cornish TC; Olino K; Meriden Z; Choti M; Diaz LA; Pawlik TM; Schulick RD; Hruban RH; Edil BH
    Ann Surg; 2014 Feb; 259(2):204-12. PubMed ID: 23673766
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimized modification of the eighth edition of AJCC TNM staging system for resected pancreatic ductal adenocarcinoma.
    Pu N; Yin L; Habib JR; Gao S; Hu H; Zhu Y; Wu Y; Yu J; Lou W
    Future Oncol; 2019 Oct; 15(30):3457-3465. PubMed ID: 31460788
    [No Abstract]   [Full Text] [Related]  

  • 39. Multi-institutional Validation Study of the American Joint Commission on Cancer (8th Edition) Changes for T and N Staging in Patients With Pancreatic Adenocarcinoma.
    Allen PJ; Kuk D; Castillo CF; Basturk O; Wolfgang CL; Cameron JL; Lillemoe KD; Ferrone CR; Morales-Oyarvide V; He J; Weiss MJ; Hruban RH; Gönen M; Klimstra DS; Mino-Kenudson M
    Ann Surg; 2017 Jan; 265(1):185-191. PubMed ID: 27163957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Prognostic Value of the AJCC 8th Edition Staging System for Patients Undergoing Neoadjuvant Chemotherapy for Breast Cancer.
    Kantor O; Bao J; Jaskowiak N; Yao K; Tseng J
    Ann Surg Oncol; 2020 Feb; 27(2):352-358. PubMed ID: 31376037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.